loader
Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Citicoline Sodium Active Pharmaceutical Ingredient (API)

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Citicoline Sodium

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 189Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    01/01/2018 Bajaj Healthcare
    India
    		 M/s Bajaj Healthcare Limited WC-0380 Citicoline Sodium IH 2016-08-01 2019-08-01 Plot No.1717 & 1718, G.I.D.C Panoli, Tal. Ankleshwar, Dist. Bharuch-394 116, Gujarat India
    10/07/2021 Solara Active Pharma Sciences
    India
    		 M/s Solara Active Pharma Sciences limited WC-0294 Citicoline Sodium 2021-08-06 2024-03-04 R.S No.33 and 34 Mathur Road Periyakalapet, Punducherry India